# Oxybutynin Chloride Extended Release

NDC: 62175-271
Generic name: Oxybutynin Chloride
Labeler / Manufacturer: Lannett Company, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, EXTENDED RELEASE
Routes: ORAL
Marketing started: 20090301

FDA application: ANDA078503

## Active ingredients

- OXYBUTYNIN CHLORIDE: 10 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"62175-271"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=62175-271
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c5950dba-d92b-46a0-993f-af9f9ddb52bf